Genus
Genus plc is a British animal genetics biotechnology company delivering elite breeding technology to the global livestock industry. The company uses biotechnology and genomic selection to breed elite pigs under the PIC brand and dairy and beef cattle under the ABS brand, alongside offering bovine artificial insemination and sexed semen technology. Main revenue drivers include commercial sales of elite breeding pigs, bovine semen straws, embryo transfer services, and gene-editing royalty agreements. Genus serves commercial pork producers, dairy farmers, and beef cattle breeders across North America, Latin America, Europe, and Asia. The company holds a world-dominant market position in porcine and bovine genetics and livestock breeding technology. Headquartered in Basingstoke, United Kingdom, Genus plc is listed on the London Stock Exchange.
7 of the funds FundTelligence covers report a position in Genus.
- Legal name
- Genus PLC
- Sector
- Health Care
- Country
- United Kingdom
- Funds holding it
- 7
- Exposure themes
- Agricultural Technology & Inputs, Food & Agriculture Transformation, Inputs & Biologicals
Funds holding Genus
- T. Rowe Price European Smaller Companies Equity — T. Rowe Price · 1.35 % (full portfolio disclosed, September 2026)
- Indecap Guide Global Offensiv — Indecap · 0.41 % (full portfolio disclosed, June 2026)
- Nordea BetaPlus Enhanced Global Sustainable Small Cap — Nordea Funds · 0.09 % (full portfolio disclosed, September 2026)
- Handelsbanken Global SMB Index Criteria — Handelsbanken · 0.02 % (full portfolio disclosed, October 2026)
- DNB Global Enhanced Small Cap — DNB · 0.02 % (full portfolio disclosed, September 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.02 % (partially disclosed portfolio, June 2026)
- Nordea Internationale aktier — Nordea Funds · 0.0 % (full portfolio disclosed, September 2026)